Home Compare DGE.L vs REGN
Stock Comparison · Broad operating lead

Diageo vs Regeneron Pharmaceuticals: Which Stock Looks Stronger in 2026?

Regeneron Pharmaceuticals holds the cleaner structural position, with growth as the main driver and valuation adding further support. Diageo does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (DGE.L: STOXX 600, REGN: Nasdaq 100).

Updated 2026-05-17

This is not just a one-metric split: both growth and valuation materially support the lead. The overall score gap is 23 points in favour of Regeneron Pharmaceuticals, Inc..

Trajectory Similarity
0.62
Moderately similar
Peer-set rank: #19
within Diageo plc's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The clearest structural overlap shows up in recent revenue growth and margin trend.

Similarity drivers
recent revenue growthmargin trend
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
DGE.L
Diageo plc
47
Peer-Score
Signal qualitylow
Peer basis: STOXX 600
vs
REGN
Regeneron Pharmaceuticals, Inc.
70
Peer-Score
Signal qualitylow
Peer basis: Nasdaq 100

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

More than one operating dimension supports the result here.

Dimension spread: DGE.L vs REGN Profitability 49 70 Stability 37 57 Valuation 62 85 Growth 31 62 DGE.L REGN
Gap Ranking
#1 Growth +31
#2 Valuation +23
#3 Profitability +21
#4 Stability +20
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for DGE.L and REGN Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer DGE.LREGN Relative valuation Structural strength

Regeneron Pharmaceuticals, Inc. looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
On growth, Regeneron Pharmaceuticals, Inc. is positioned higher in the group, while Diageo plc is closer to the middle.
Valuation
Both profiles are strong on valuation, but Regeneron Pharmaceuticals, Inc. leads clearly.
Growth — Dominant Gap
DGE.L
31
REGN
62
Gap+31in favour of REGN

One company is still expanding while the other is contracting, which creates a very wide growth split.

What else supports the lead

Absolute pricing gives the lead a second hard layer of support, with a trailing P/E that is 2.1 turns lower.

What this means for the comparison

Growth is the clearest driver, and valuation also supports Regeneron Pharmaceuticals, Inc.'s broader structural position.

Explore full peer positioning in AssetNext

Break down the DGE.L vs REGN comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-valuation comparisons

Explore how DGE.L and REGN each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.